CASP12 and uterine cervix neoplasm: Further, QNZ treatment decreased caspase-12 cleavage asindicated by increasing full-length caspase-12, and abrogated caspase-3 cleavagefollowing BFA in cervical tumor cells (Figures 6c and d).Furthermore, QNZ attenuated the TC-1 tumor cell death induced by BFA (Figure 7a).